Logo image of ALSPT.PA

SPARTOO (ALSPT.PA) Stock Fundamental Analysis

EPA:ALSPT - Euronext Paris - Matif - FR00140043Y1 - Common Stock - Currency: EUR

0.358  -0.02 (-4.28%)

Fundamental Rating

3

Taking everything into account, ALSPT scores 3 out of 10 in our fundamental rating. ALSPT was compared to 53 industry peers in the Specialty Retail industry. Both the profitability and financial health of ALSPT have multiple concerns. ALSPT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALSPT has reported negative net income.
In the past year ALSPT had a positive cash flow from operations.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of ALSPT (-1.22%) is comparable to the rest of the industry.
The Return On Equity of ALSPT (-3.53%) is comparable to the rest of the industry.
ALSPT has a Return On Invested Capital of 4.68%. This is in the better half of the industry: ALSPT outperforms 62.26% of its industry peers.
Industry RankSector Rank
ROA -1.22%
ROE -3.53%
ROIC 4.68%
ROA(3y)-1.7%
ROA(5y)N/A
ROE(3y)-5.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

ALSPT has a Operating Margin of 2.27%. This is comparable to the rest of the industry: ALSPT outperforms 58.49% of its industry peers.
In the last couple of years the Operating Margin of ALSPT has declined.
With a decent Gross Margin value of 52.09%, ALSPT is doing good in the industry, outperforming 79.25% of the companies in the same industry.
ALSPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.27%
PM (TTM) N/A
GM 52.09%
OM growth 3Y-21.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.16%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 20 30 40 50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALSPT is destroying value.
The number of shares outstanding for ALSPT remains at a similar level compared to 1 year ago.
ALSPT has a worse debt/assets ratio than last year.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ALSPT has an Altman-Z score of 1.71. This is a bad value and indicates that ALSPT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.71, ALSPT is in line with its industry, outperforming 50.94% of the companies in the same industry.
ALSPT has a debt to FCF ratio of 5.66. This is a neutral value as ALSPT would need 5.66 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.66, ALSPT is in line with its industry, outperforming 52.83% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that ALSPT is somewhat dependend on debt financing.
ALSPT has a Debt to Equity ratio of 0.53. This is comparable to the rest of the industry: ALSPT outperforms 56.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.66
Altman-Z 1.71
ROIC/WACC0.85
WACC5.53%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.90 indicates that ALSPT should not have too much problems paying its short term obligations.
ALSPT has a better Current ratio (1.90) than 84.91% of its industry peers.
A Quick Ratio of 0.62 indicates that ALSPT may have some problems paying its short term obligations.
ALSPT has a Quick ratio (0.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.62
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

2

3. Growth

3.1 Past

ALSPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.83%, which is quite impressive.
Looking at the last year, ALSPT shows a decrease in Revenue. The Revenue has decreased by -8.67% in the last year.
Measured over the past years, ALSPT shows a small growth in Revenue. The Revenue has been growing by 1.52% on average per year.
EPS 1Y (TTM)39.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)-8.67%
Revenue growth 3Y1.52%
Revenue growth 5YN/A
Sales Q2Q%-10.49%

3.2 Future

ALSPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.98% yearly.
The Revenue is expected to decrease by -1.79% on average over the next years.
EPS Next Y63.16%
EPS Next 2Y45.1%
EPS Next 3Y38.98%
EPS Next 5YN/A
Revenue Next Year-8.36%
Revenue Next 2Y-4.25%
Revenue Next 3Y-1.79%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 34.76, the valuation of ALSPT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALSPT is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ALSPT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 34.76
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSPT indicates a rather cheap valuation: ALSPT is cheaper than 94.34% of the companies listed in the same industry.
94.34% of the companies in the same industry are more expensive than ALSPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.61
EV/EBITDA 2.03
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSPT's earnings are expected to grow with 38.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.1%
EPS Next 3Y38.98%

0

5. Dividend

5.1 Amount

No dividends for ALSPT!.
Industry RankSector Rank
Dividend Yield N/A

SPARTOO

EPA:ALSPT (3/7/2025, 7:00:00 PM)

0.358

-0.02 (-4.28%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners36.24%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.51M
Analysts82
Price Target0.87 (143.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)63.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.76
P/S 0.05
P/FCF 1.61
P/OCF 1.31
P/B 0.21
P/tB 0.25
EV/EBITDA 2.03
EPS(TTM)-0.07
EYN/A
EPS(NY)0.01
Fwd EY2.88%
FCF(TTM)0.22
FCFY62.04%
OCF(TTM)0.27
OCFY76.21%
SpS7.44
BVpS1.7
TBVpS1.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.22%
ROE -3.53%
ROCE 6.36%
ROIC 4.68%
ROICexc 6.03%
ROICexgc 6.93%
OM 2.27%
PM (TTM) N/A
GM 52.09%
FCFM 2.99%
ROA(3y)-1.7%
ROA(5y)N/A
ROE(3y)-5.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-32.98%
ROICexcg growth 5YN/A
ROICexc growth 3Y-32.29%
ROICexc growth 5YN/A
OM growth 3Y-21.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.16%
GM growth 5YN/A
F-Score6
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.66
Debt/EBITDA 1.8
Cap/Depr 15.18%
Cap/Sales 0.68%
Interest Coverage 250
Cash Conversion 54.21%
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 0.62
Altman-Z 1.71
F-Score6
WACC5.53%
ROIC/WACC0.85
Cap/Depr(3y)33.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y63.16%
EPS Next 2Y45.1%
EPS Next 3Y38.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.67%
Revenue growth 3Y1.52%
Revenue growth 5YN/A
Sales Q2Q%-10.49%
Revenue Next Year-8.36%
Revenue Next 2Y-4.25%
Revenue Next 3Y-1.79%
Revenue Next 5YN/A
EBIT growth 1Y31.86%
EBIT growth 3Y-20.02%
EBIT growth 5YN/A
EBIT Next Year185.71%
EBIT Next 3Y69.35%
EBIT Next 5YN/A
FCF growth 1Y134.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.41%
OCF growth 3Y30.84%
OCF growth 5YN/A